Dr. Deepak George
Consultant - Medical Oncolgy and BMT
Dr. Deepak George is a dedicated and passionate Medical Oncolgy and BMT with over a decade of rich clinical experience. He holds an MD in Radiation Oncology and a DM in Medical Oncology, combining deep expertise with an empathetic approach to patient care. He is known for his commitment to providing personalized, evidence-based treatment plans tailored to each patient’s needs. With a profound understanding of the latest advancements in oncology, Dr. Deepak George consistently strives for excellence in outcomes and holistic well-being. He specializes in the management of leukaemia, lymphoma, and myeloma, and is skilled in performing autologous and allogeneic bone marrow transplants using TMLI, including unrelated donor and haploidentical transplants. His clinical focus also extends to immunotherapy, CAR-T cell therapy, and advanced cellular therapies.
Experience
- Consultant (May 2025 – Present), Apollo Cancer Centre, Chennai
- Associate Consultant (May 2024 – April 2025), Apollo Cancer Centre, Chennai
- Associate Consultant (Oct 2023 – 2025)
- Junior Consultant (Sep 2022 – Sep 2023)
Education
- Harvard Medical School, Advanced Management of Oncological Diseases – 2025
- ESMO, European Society for Medical Oncology – 2022
- DM Medical Oncology, Government Medical College, Kilpauk – MGR University, Chennai – 2022
- MD Radiotherapy (Radiation Oncology), Government Medical College, Thrissur – Kerala University of Health Sciences – 2016
- MBBS, Jubilee Mission Medical College & Research Institute – Calicut University, Kerala – 2009
Research and Publications
- A NUDT15 Genetic Polymorphism Study in Adult Acute Leukemia Patients Integrating Pharmacogenomics and Clinical Practice: A Single Centre Experience from South India – Blood Journal, Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms, Nov 2, 2023
- Combination of Venetoclax and Azacytidine As First-Line Induction Therapy for Acute Myeloid Leukemia in Patients Younger Than 60 Years: A Tertiary Care Center Experience from Our Low Middle Income Country – Blood Journal, Acute Myeloid Leukemias: Clinical and Epidemiological, Nov 2, 2023
- A retrospective study on the clinicopathological characteristics of colorectal cancer in younger adults (<50 years) – International Journal of Advanced Medicine, Jan 2022, Vol 9 (1), pp. 1905–1910
Authors: Deepak George, J Kannan, Srigopal Mohanty, N Ingersal - Analyzing the pattern of distant metastasis and exploring clinico-pathological factors linked to de-novo metastatic cervical cancer – International Journal of Research in Medical Sciences (IJRMS), Vol 10 (1)
Authors: J Kannan, Amit Saklani, Srigopal Mohanty, Kiranmayee Narapaneni, Deepak George, N Ingersa - Exploring esophageal cancer in South India – a 5-year retrospective analysis – Global Journal for Research Analysis (GJRA), Mar 2021, Vol 10 (3)
Authors: R Ramkumar, J Kannan, Srigopal Mohanty, Amit Saklani, Deepak George, N Ingersa - Prospective analysis of toxicities and quality of life in patients with advanced carcinoma cervix following concurrent chemo-radiation with weekly cisplatin – International Journal of Scientific Study, Sep 2018, Vol 6 (60)
- Prospective survival analysis in locally advanced carcinoma cervix patients treated with concurrent chemo-radiation with weekly cisplatin – International Journal of Scientific Study, Jan 2017, Vol 5 (1), pp. 153–156
Authors: Jayaraman B, Shahana A, Deepak G, Mahadevan R.A
Special Interests
- Management of leukaemia, lymphoma, and myeloma
- Bone marrow transplantation using TMLI (autologous, allogeneic, unrelated, and haploidentical)
- Immunotherapy and CAR-T cell therapy
- Cellular therapy
Conditions and Procedures
- Leukaemia
- Lymphoma
- Myeloma
- Bone marrow transplantation (TMLI, autologous, allogeneic, haploidentical)
- Immunotherapy / CAR-T cell therapy
Winning Over Cancer
